CIK 0001816736 · Large accelerated filer
Disc Medicine, Inc.
Sign in to watch- Ticker
- IRON
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 851612845
- Phone
- (617) 674-9274
- Business address
- 321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
- Former names
- Gemini Therapeutics, Inc. /DE, FS Development Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $14,489,047
- in 7 filings, $12.6M under 10b5-1 plans
Net −$14,489,047. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-10 | Savage William Jacob Chief Medical Officer | Sale 10b5-1 | −16,035 | $85.09 | $1.4M | 63,445 |
| 2026-10-21 | Bitterman Kevin Director | Sale 10b5-1 | −13,783 | $80.23 | $1.1M | 296,277 |
| 2026-10-21 | Bitterman Kevin Director | Sale 10b5-1 | −11,470 | $80.23 | $920K | 293,430 |
| 2026-10-21 | Bitterman Kevin Director | Sale 10b5-1 | −266 | $80.23 | $21K | 12,991 |
| 2026-10-20 | Bitterman Kevin Director | Sale 10b5-1 | −2,869 | $79.95 | $229K | 310,060 |
| 2026-10-20 | Bitterman Kevin Director | Sale 10b5-1 | −2,388 | $79.95 | $191K | 304,900 |
| 2026-10-20 | Bitterman Kevin Director | Sale 10b5-1 | −55 | $79.95 | $4K | 13,257 |
| 2026-10-19 | Bitterman Kevin Director | Sale 10b5-1 | −5,937 | $79.97 | $475K | 312,929 |
| 2026-10-19 | Bitterman Kevin Director | Sale 10b5-1 | −4,942 | $79.97 | $395K | 307,288 |
| 2026-10-19 | Bitterman Kevin Director | Sale 10b5-1 | −115 | $79.97 | $9K | 13,312 |
| 2026-09-15 | Quisel John D Chief Executive Officer | Option exercise | +36,000 | $1.01 | $36K | 262,064 |
| 2026-09-15 | Quisel John D Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −36,000 | 150,120 | ||
| 2026-09-11 | Bitterman Kevin Director | Option exercise | +7,136 | $45.69 | $326K | 7,136 |
| 2026-09-11 | Bitterman Kevin Director | Option exercise | +10,000 | $38.85 | $389K | 17,136 |
| 2026-09-11 | Bitterman Kevin Director | Option exercise | +10,000 | $50.86 | $509K | 27,136 |
| 2026-09-11 | Bitterman Kevin Director | Sale | −27,136 | $70.11 | $1.9M | 0 |
| 2026-09-11 | Bitterman Kevin Director | Option exercise · Stock Option (Right to Buy) | −7,136 | 0 | ||
| 2026-09-11 | Bitterman Kevin Director | Option exercise · Stock Option (Right to Buy) | −10,000 | 0 | ||
| 2026-09-11 | Bitterman Kevin Director | Option exercise · Stock Option (Right to Buy) | −10,000 | 0 | ||
| 2026-09-04 | Bitterman Kevin Director | Sale 10b5-1 | −912 | $79.96 | $73K | 318,866 |
Page 1 of 17 · 337 trades